Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From BOLERO-2

PURPOSE: To explore the genetic landscape of tumors from patients enrolled on the BOLERO-2 trial to identify potential correlations between genetic alterations and efficacy of everolimus treatment. The BOLERO-2 trial has previously demonstrated that the addition of everolimus to exemestane prolonged...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Oncol
Auteurs principaux: Hortobagyi, Gabriel N., Chen, David, Piccart, Martine, Rugo, Hope S., Burris, Howard A., Pritchard, Kathleen I., Campone, Mario, Noguchi, Shinzaburo, Perez, Alejandra T., Deleu, Ines, Shtivelband, Mikhail, Masuda, Norikazu, Dakhil, Shaker, Anderson, Ian, Robinson, Douglas M., He, Wei, Garg, Abhishek, McDonald, E. Robert, Bitter, Hans, Huang, Alan, Taran, Tetiana, Bachelot, Thomas, Lebrun, Fabienne, Lebwohl, David, Baselga, José
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2016
Sujets:
ORIGINAL REPORTS
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070556/
https://ncbi.nlm.nih.gov/pubmed/26503204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.60.1971
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires